NCT03276494View on ClinicalTrials.gov

Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 21, 2017

Primary Completion Date

April 21, 2018

Study Completion Date

April 21, 2018

Conditions
StrokeIntracranial HypotensionCerebral Edema
Interventions
DEVICE

Intraosseous

Intraosseous administration of hypertonic saline

DRUG

Hypertonic saline

Intraosseous administration of hypertonic saline

Trial Locations (1)

43210

The Ohio State University, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER

NCT03276494 - Safety & Tolerability of Hypertonic Saline Administration Via Intraosseous Access | Biotech Hunter | Biotech Hunter